Works matching IS 10452257 AND DT 2015 AND VI 54 AND IP 1
Results: 5
Copy number variations could predict the outcome of bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 1, p. 20, doi. 10.1002/gcc.22213
- By:
- Publication type:
- Article
A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: A pathologic and molecular study of 18 cases.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 1, p. 28, doi. 10.1002/gcc.22215
- By:
- Publication type:
- Article
Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 1, p. 39, doi. 10.1002/gcc.22217
- By:
- Publication type:
- Article
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 1, p. 51, doi. 10.1002/gcc.22218
- By:
- Publication type:
- Article
Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 1, p. 1, doi. 10.1002/gcc.22221
- By:
- Publication type:
- Article